Search research articles
Contact Us
Filters
Showing results (31-40 of 173) with videos related to
Page
of 18
Sort By:
Pharmacological Reviews
|
June 1, 2004
The significance of vasoactive intestinal peptide in immunomodulation
Mario Delgado, David Pozo, Doina Ganea
Current Opinion in Pharmacology
|
April 20, 2010
Neuropeptides: keeping the balance between pathogen immunity and immune tolerance
Elena Gonzalez-Rey, Doina Ganea, Mario Delgado
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
July 3, 2004
VIP/PACAP preferentially attract Th2 effectors through differential regulation of chemokine production by dendritic cells
Mario Delgado, Elena Gonzalez-Rey, Doina Ganea
Pharmaceutics
|
December 23, 2022
Therapeutic Effect of a Latent Form of Cortistatin in Experimental Inflammatory and Fibrotic Disorders
Jenny Campos-Salinas, Margarita Barriga, Mario Delgado
Nature Reviews. Immunology
|
December 23, 2006
Regulation of immune tolerance by anti-inflammatory neuropeptides
Elena Gonzalez-Rey, Alejo Chorny, Mario Delgado
Glia
|
April 30, 2008
Vasoactive intestinal peptide protects against beta-amyloid-induced neurodegeneration by inhibiting microglia activation at multiple levels
Mario Delgado, Nieves Varela, Elena Gonzalez-Rey
Annals of the New York Academy of Sciences
|
August 5, 2006
Vasoactive intestinal peptide: the dendritic cell --> regulatory T cell axis
Mario Delgado, Elena Gonzalez-Rey, Doina Ganea
Annals of the New York Academy of Sciences
|
August 5, 2006
VIP: an agent with license to kill infective parasites
Elena Gonzalez-Rey, Alejo Chorny, Mario Delgado
Journal of Immunology (Baltimore, Md. : 1950)
|
November 23, 2005
The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells
Mario Delgado, Elena Gonzalez-Rey, Doina Ganea
Glia
|
July 12, 2002
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia
Mario Delgado, G Miller Jonakait, Doina Ganea
Page
of 18
Search research articles
Search
Showing results (31-40 of 173) with videos related to
Sort By:
Page
of 18
Pharmacological Reviews
|
June 1, 2004
The significance of vasoactive intestinal peptide in immunomodulation
Mario Delgado, David Pozo, Doina Ganea
Current Opinion in Pharmacology
|
April 20, 2010
Neuropeptides: keeping the balance between pathogen immunity and immune tolerance
Elena Gonzalez-Rey, Doina Ganea, Mario Delgado
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
July 3, 2004
VIP/PACAP preferentially attract Th2 effectors through differential regulation of chemokine production by dendritic cells
Mario Delgado, Elena Gonzalez-Rey, Doina Ganea
Pharmaceutics
|
December 23, 2022
Therapeutic Effect of a Latent Form of Cortistatin in Experimental Inflammatory and Fibrotic Disorders
Jenny Campos-Salinas, Margarita Barriga, Mario Delgado
Nature Reviews. Immunology
|
December 23, 2006
Regulation of immune tolerance by anti-inflammatory neuropeptides
Elena Gonzalez-Rey, Alejo Chorny, Mario Delgado
Glia
|
April 30, 2008
Vasoactive intestinal peptide protects against beta-amyloid-induced neurodegeneration by inhibiting microglia activation at multiple levels
Mario Delgado, Nieves Varela, Elena Gonzalez-Rey
Annals of the New York Academy of Sciences
|
August 5, 2006
Vasoactive intestinal peptide: the dendritic cell --> regulatory T cell axis
Mario Delgado, Elena Gonzalez-Rey, Doina Ganea
Annals of the New York Academy of Sciences
|
August 5, 2006
VIP: an agent with license to kill infective parasites
Elena Gonzalez-Rey, Alejo Chorny, Mario Delgado
Journal of Immunology (Baltimore, Md. : 1950)
|
November 23, 2005
The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells
Mario Delgado, Elena Gonzalez-Rey, Doina Ganea
Glia
|
July 12, 2002
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia
Mario Delgado, G Miller Jonakait, Doina Ganea
Page
of 18